CYTOTOXIC CD4+ T CELLS AS NOVEL IMMUNOTHERAPY IN CLL AND OTHER B-CELL MALIGNANCIES

Project Details

AcronymKILLERCD4-CLL
StatusFinished
Effective start/end date1/10/22 → 30/09/24